Sign In
Buy BOLT
$4.63
-0.480 (-9.39%)
At Close: Jun 03, 2026
Bolt Biotherapeutics Aims For $150 Million U.S. IPO
01:53pm, Tuesday, 02'nd Feb 2021
Bolt Biotherapeutics has filed proposed terms for a $150 million IPO. The firm is developing antibody conjugate treatments for various cancers.
